Thermo Fisher Scientific Strengthens Life Sciences Leadership with New Instruments Launched at ASMS 2016
June 06 2016 - 8:00AM
Business Wire
Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in
serving science, strengthened its industry-leading analytical
instruments platform with innovative systems designed to help
pharmaceutical and biologics producers more efficiently discover
and develop candidate drugs. These new products will be on display
at the 64th Annual American Society for Mass Spectrometry (ASMS)
Conference, June 5-9 in Texas Ballroom D at the Grand Hyatt
Hotel.
“The success of our innovation strategy is based on continuous
collaboration with our customers,” said Marc N. Casper, president
and chief executive officer Thermo Fisher Scientific. “Our mission
is to enable our customers to make the world healthier, cleaner and
safer, and we are committed to providing them with the most
advanced analytical technologies to help them facilitate research
and accelerate discovery. This year’s ASMS showing is another great
example of how we continue to leverage our technology leadership to
raise the performance bar and help our customers achieve their
goals.”
The new Thermo Scientific Q Exactive BioPharma MS/MS
Hybrid Quadropole-Orbitrap mass spectrometer takes full advantage
of the high-resolution, accurate-mass (HRAM) capabilities of the
Orbitrap mass analyzer to enable key workflows for protein
characterization in a single instrument. Combined with recommended
sample preparation and analysis methods using Thermo Scientific
reagents, columns, UHPLC and data processing technologies, the Q
Exactive BioPharma system provides a comprehensive solution for
customers performing biopharmaceutical characterization.
At ASMS, Thermo Fisher will also feature its new Thermo
Scientific Vanquish Flex Binary UHPLC system, an ideal
complement for pharmaceutical and biopharmaceutical laboratories
performing qualitative and quantitative LC or LC-MS analysis. Built
for high-speed and fast gradient applications, the Vanquish
platform delivers outstanding reproducibility.
As part of its focus on innovation, Thermo Fisher will feature
new technology from 908 Devices, a pioneer in purpose-built
analytical devices for chemical analysis. Customers using Thermo
Fisher’s mass spectrometers can now incorporate 908 Devices’
breakthrough ZipChip microfluidics separation technology to deliver
fast, high-quality separations that transform analysis of
biomolecules.
Thermo Fisher will also showcase high-profile collaborations
through presentations and posters by notable scientists doing
breakthrough work with its mass spectrometry technologies.
- Dr. Willi Haas, assistant professor at
Harvard Medical School, will present the Advances in Accurate,
High-Throughput Quantitative Proteomics Breakfast
Workshop. His approach combines Orbitrap HRAM MS and
synchronous precursor selection (SPS)-based MS3 technology on the
Thermo Scientific Orbitrap Tribrid MS system to accurately measure
the smallest changes in low-abundance proteins.
- Dr. Fan Liu from the Albert Heck Lab,
Utrecht University, Netherlands, will present the Improved
Workflows for Structural Proteomics Breakfast Workshop.
Dr. Liu’s lab is using Orbitrap technology for proteome-wide
cross-linking mass spectrometry to chart the cellular interactome,
the whole set of molecular interactions in a single cell.
- Dr. Jennifer Abelin from the Eli and
Edythe L. Broad Institute of MIT and Harvard will present
High-throughput Profiling of HLA Allele-specific Peptides by MS
for Improved Epitope Predictions at the Thermo Fisher Annual
User Meeting. She will discuss her use of LC-MS/MS techniques to
improve the understanding of antigen processing to identify
peptides in diseases including cancer, inflammatory bowel disease
and infectious diseases.
- Dr. Akhilesh Pandey, John Hopkins
University School of Medicine, will present Getting Ready for
Clinical Proteomics at the Thermo Fisher Annual User
Meeting. Dr. Pandey will discuss the emerging use of
proteomics in a clinical setting. Dr. Pandey is best known for his
groundbreaking research in the mapping of the human proteome
http://www.humanproteomemap.org.
Finally, Thermo Fisher will recognize the winners of the 2016
Thermo Scientific Tandem Mass Tag (TMT) Research Awards, an
international research grant for scientists and their work in
proteomics.
Thermo Fisher will be exhibiting in Booth 319 at the Henry B.
Gonzalez Convention Center and in Texas Ballroom D at the Grand
Hyatt Hotel in San Antonio. For more information please visit
http://www.thermofisher.com/asms.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving
science, with revenues of $17 billion and more than 50,000
employees in 50 countries. Our mission is to enable our customers
to make the world healthier, cleaner and safer. We help our
customers accelerate life sciences research, solve complex
analytical challenges, improve patient diagnostics and increase
laboratory productivity. Through our premier brands – Thermo
Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and
Unity Lab Services – we offer an unmatched combination of
innovative technologies, purchasing convenience and comprehensive
support. For more information, please visit
www.thermofisher.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160606005391/en/
Thermo Fisher Scientific Inc.Media:Ron O’Brien,
781-622-1242ron.obrien@thermofisher.comwww.thermofisher.comorInvestors:Ken
Apicerno, 781-622-1294ken.apicerno@thermofisher.com
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Apr 2023 to Apr 2024